Cardenolides and bufadienolide glycosides from Kalanchoe tubiflora and evaluation of cytotoxicity

Planta Med. 2013 Sep;79(14):1362-9. doi: 10.1055/s-0033-1350646. Epub 2013 Jul 22.

Abstract

Two new cardenolides, kalantubolide A (1) and kalantubolide B (2), and two bufadienolide glycosides, kalantuboside A (3) and kalantuboside B (4), as well as eleven known compounds were isolated and characterized from the EtOH extract of Kalanchoe tubiflora. The structures of compounds were assigned based on 1D and 2D NMR spectroscopic analyses including HMQC, HMBC, and NOESY. Biological evaluation indicated that cardenolides (1-2) and bufadienolide glycosides (3-7) showed strong cytotoxicity against four human tumor cell lines (A549, Cal-27, A2058, and HL-60) with IC50 values ranging from 0.01 µM to 10.66 µM. Cardenolides (1-2) also displayed significant cytotoxicity toward HL-60 tumor cell line. In addition, compounds 3, 4, 5, 6, and 7 blocked the cell cycle in the G2/M-phase and induced apoptosis in HL-60 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Phytogenic / chemistry
  • Antineoplastic Agents, Phytogenic / isolation & purification
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Apoptosis / drug effects
  • Cardenolides / chemistry
  • Cardenolides / isolation & purification
  • Cardenolides / pharmacology
  • Cardenolides / therapeutic use*
  • Cell Cycle Checkpoints / drug effects
  • HL-60 Cells
  • Humans
  • Kalanchoe / chemistry*
  • Neoplasms / drug therapy
  • Phytotherapy*
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use

Substances

  • Antineoplastic Agents, Phytogenic
  • Cardenolides
  • Plant Extracts
  • kalantubolide A
  • kalantubolide B